Ticker League

Operating Income for Edwards Lifesciences (EW)

Latest filings through · Reported

Metric

TTM

$1.74B

YoY change

+18.7%

5Y CAGR

+4.8%

Peak year (2022)

$1.70B

Operating Income history chart for Edwards Lifesciences (EW) from 1999 to 2025

Latest: $1.64B

Operating Income growth chart for Edwards Lifesciences (EW) from 1999 to 2025

Latest: +18.7%

Operating Income history table for Edwards Lifesciences (EW) from 1999 to 2025

  • 2025$1.64B+18.7%
  • 2024$1.38B-3.4%
  • 2023$1.43B-16.2%
  • 2022$1.70B+5.7%
  • 2021$1.61B+24.3%
  • 2020$1.30B+8.2%
  • 2019$1.20B+9.7%
  • 2018$1.09B+8.1%
  • 2017$1.01B+23.9%
  • 2016$815.50M+41.6%
  • 2015$575.90M+18.2%
  • 2014$487.20M+12.5%
  • 2013$433.00M+9.2%
  • 2012$396.70M+20.5%
  • 2011$329.10M+16.5%
  • 2010$282.50M+21.2%
  • 2009$233.00M+11.5%
  • 2008$209.00M+23.3%
  • 2007$169.50M+3.7%
  • 2006$163.50M-6.9%
  • 2005$175.60M+13.7%
  • 2004$154.40M+11.6%
  • 2003$138.40M+165.6%
  • 2002$52.10M+117.1%
  • 2001$24.00M-74.7%
  • 2000$95.00M-18.8%
  • 1999$117.00M—

Operating Income values are taken from Edwards Lifesciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Income at Edwards Lifesciences (EW)

According to Edwards Lifesciences's latest reported financial statements, the company's current operating income (TTM) is $1.74B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Edwards Lifesciences (EW) operating income is $1.64B – grew 18.7% year-over-year.

Edwards Lifesciences operating income has grown on net over the period, with a +4.8% compound annual growth rate over 2020–2025 (5 years).

Edwards Lifesciences operating income peaked at $1.70B in 2022; the latest annual figure is $1.64B in 2025 (3.9% below peak).

2022 marks the peak operating income at $1.70B, with the historical low of $24.00M recorded in 2001.

Edwards Lifesciences Operating Income by Year

Edwards Lifesciences Operating Income 2025: $1.64B

In 2025, Edwards Lifesciences reported operating income of $1.64B, grew 18.7% from 2024.

Edwards Lifesciences Operating Income 2024: $1.38B

Edwards Lifesciences operating income in 2024 was $1.38B, edged down 3.4% below 2023.

Edwards Lifesciences Operating Income 2023: $1.43B

2023's operating income for Edwards Lifesciences came in at $1.43B, declined 16.2% below 2022.

Edwards Lifesciences Operating Income 2022: $1.70B

Edwards Lifesciences posted operating income of $1.70B in 2022, grew 5.7% from 2021. This figure represents the highest annual value in the available history.

Edwards Lifesciences Operating Income 2021: $1.61B

Edwards Lifesciences operating income in 2021 was $1.61B.

See more financial history for Edwards Lifesciences (EW).

Sector peers by Operating Income

Healthcare peers of Edwards Lifesciences (EW), ranked by their latest operating income

Frequently asked questions

Edwards Lifesciences (EW) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview